SCHEMBL20360757

SCHEMBL20360757

N#CC1CCS(=N)(=O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2005873 0.79
SCHEMBL11440982 0.70
SCHEMBL1164553 0.67 KDM4E (0.34)
SCHEMBL1343696 0.67 KDM4E (0.34)
SCHEMBL45941 0.67 KDM4E (0.34)
SCHEMBL6618 0.67
SCHEMBL4189681 0.65
SCHEMBL13742560 0.65
SCHEMBL28386367 0.65
Ammonia Solution, Strong SCHEMBL16007514 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053239-B2 Compounds as BLC-2-selective apoptosis-inducing agents FOCHON PHARMACEUTICALS, LTD. (CN) 2021-07-06 US disclosed
US-20190345156-A1 COMPOUNDS AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS SHANGHAI FOCHON PHARMACEUTICAL CO., LTD. (CN) 2019-11-14 US disclosed
EP-3565815-A1 COMPOUNDS AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS Shanghai Fochon Pharmaceutical Co., Ltd. (CN) 2019-11-13 EP disclosed
WO-2018127130-A1 COMPOUNDS AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS SHANGHAI FOCHON PHARMACEUTICAL CO., LTD. (CN) 2018-07-12 WO disclosed